SPONSOR
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
How many clinical trials has K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, of which 1 are actively recruiting participants. These trials cover conditions including High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc research focus on?
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc clinical trials span High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc clinical trial?
To participate in a K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc trials with current recruitment status updated daily.
Clinical Trials by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology